Therapeutic cotinine compositions
AssigneeUniversity of Louisville Research Foubdation
InventorsDavid Albert Scott, Michael Martin
Life of this patent
Estimating the term…
Abstract
The present invention provides methods and compositions for treating acute and/or chronic inflammation with cotinine or a pharmaceutically acceptable salt thereof.
Claims26
A method to treat acute inflammation comprising administering a therapeutically effective amount of cotinine, or a pharmaceutically acceptable salt thereof, to a mammal.
A method to treat chronic inflammation, excluding inflammatory bowel disorders (IBD), comprising administering a therapeutically effective amount of cotinine, or a pharmaceutically acceptable salt thereof, to a mammal.
A method of modulating activity of a cytokine comprising administering a therapeutically effective amount of cotinine, or a pharmaceutically acceptable salt thereof, to a mammal.
The use of cotinine, or a pharmaceutically acceptable salt thereof, for the manufacture of a medicament useful for the treatment of acute inflammation in a mammal.
The use of cotinine, or a pharmaceutically acceptable salt thereof, for the manufacture of a medicament useful for the treatment of chronic inflammation, excluding inflammatory bowel disorders (IBD), in a mammal.
The use of cotinine, or a pharmaceutically acceptable salt thereof, for the manufacture of a medicament useful for the modulation of activity of a cytokine in a mammal.
A pharmaceutical composition comprising cotinine, or a pharmaceutically acceptable salt thereof, in combination with any steroidal or non-steroidal anti-inflammatory drugs(s), and a pharmaceutically acceptable diluent or carrier.
A method to suppress a pro-inflammatory response of monocytes
- comprising administering a therapeutically effective amount of cotinine to a mammal.
A method to prevent or treat acute bacterial and viral infections
- comprising administering a therapeutically effective amount of cotinine to a mammal.
A method preventing or treat a TLR-mediated inflammatory condition
- comprising administering a therapeutically effective amount of cotinine to a mammal.
An article of manufacture comprising, a packaging material and at least one unit dosage form of a pharmaceutical agent contained in the package wherein the pharmaceutical agent comprises cotinine or a pharmaceutically acceptable salt thereof in an amount effective to alleviate or reduce the symptoms of acute and/or chronic inflammation, and wherein the package includes instructions indicating use for alleviating acute and/or chronic inflammation.
Use of cotinine or a pharmaceutically acceptable salt thereof, in the manufacture of a medicament for the treatment of disease anaphylactic shock, arthritis, asthma, cholecystitis, chronic obstructive pulmonary diseases, cystitis, dacryoadenitis, dermatomyositis, dermatitis, endocarditis, endometritis, fasciitis, fibrositis, gastritis, gingivitis, glossitis, mastitis, meningitis, myelitis, myocarditis, nephritis, neuritis, orchitis, osteisis, pancreatitis, parotitis, pericarditis, periodontitis, peritonitis, phlebitis, proctitis, prostatitis, pyelonephritis, rhinitis, sepsis and septic shock, sinusitis, stomatitis, synovitis, tendonitis, tonsillitis, vaginitis, vasculitis, vascular diseases, and/or vulvitis.
Dependencies are inferred from the claim text.